Obstructive Sleep Apnea (OSA)

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Cryosa
CryosaBRENTWOOD, TN
1 program
Cryosa ProcedureN/A1 trial
Active Trials
NCT07021833Not Yet RecruitingEst. Feb 2027
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
continuous positive airway pressureN/A
UNEEG Medical
UNEEG MedicalDenmark - Allerod
1 program
continuous positive airway pressureN/A1 trial
Active Trials
NCT06711159Recruiting15Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
CryosaCryosa Procedure
UNEEG Medicalcontinuous positive airway pressure

Clinical Trials (2)

Total enrollment: 15 patients across 2 trials

NCT07021833CryosaCryosa Procedure

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea (ARCTIC_AUS)

Start: Aug 2025Est. completion: Feb 2027
N/ANot Yet Recruiting
NCT06711159UNEEG Medicalcontinuous positive airway pressure

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

Start: Oct 2024Est. completion: Dec 202515 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 15 patients
3 companies competing in this space